Programs

  • Program 1 [2018]

    MONTANA CANCER CONSORTIUM PARTICIPATES IN CLINICAL STUDIES OF CANCER PATIENTS, PROVIDES SELECTED CANDIDATES WITH EXPERIMENTAL DRUGS AND KEEPS EXTENSIVE DATA ON THE RESULTS OF TREATMENT. IN THE YEAR ENDING MAY 31, 2018, MONTANA CANCER CONSORTIUM PARTICIPATED IN APPROXIMATELY 100 CLINICAL TRIALS AND 193 PATIENTS WERE REGISTERED TO CLINICAL TRIALS. THE MONTANA CANCER CONSORTIUM MEMBERSHIP CONSISTS OF APPROXIMATELY 44 PHYSICIAN MEMBERS LOCATED ACROSS 10 AFFILIATE SITES IN MONTANA, NORTHERN WYOMING AND NORTHERN IDAHO.
    Geographies
    Not indicated
    Dates
    Jun 1, 2017 – May 31, 2018
    Source
    990
    No causes provided
    No populations provided
    –
    $799.4K

  • Montana Cancer Consortium Clinical Trials

    Montana Cancer Consortium participates in clinical studies of cancer patients, provides selected candidates with experimental drugs and keeps extensive data on the results of treatment. In the year ending May 31, 2022, Montana Cancer Consortium participated in approximately 120 clinical trials and 330 patients were registered to clinical trials. The Montana Cancer Consortium membership consists of approximately 51 physician members located across 10 affiliate sites in Montana, Northern Wyoming and Idaho.
    Geographies
    Not indicated
    Dates
    Jun 1, 2021 – May 31, 2022
    Source
    990
    No causes provided
    No populations provided
    –
    $723.9K

  • Program 1 [2025]

    The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research. In the year ending May 31, 2025, Montana Cancer Consortium participated in approximately 120 clinical trials and 374 patients were registered to clinical trials. The Montana Cancer Consortium membership consists of approximately 60 physician members located across 10 affiliate sites in Montana, Northern Wyoming and Idaho.
    Geographies
    Not indicated
    Dates
    Jun 1, 2024 – May 31, 2025
    Source
    990
    No causes provided
    No populations provided
    –
    $673.1K